INS and Insulin resistance: In a multiple-treatment meta-regression, Imamura et al. [33] demonstrated that the conversion of CHOs to SFAs lowered fasting insulin levels, the conversion to MUFA lowered HbA1c and homeostasis model assessment of insulin resistance, and the conversion to PUFA improved these outcomes, in addition to FPG and C-peptides.